Custom Health Announces Appointment of Chief Financial Officer and Board of Directors and Shareholder Approval for Proposed Public Listing

‍

May 14, 2026

Custom Health Inc. | TMX Newsfile

‍

Custom Health announced the appointment of Jason Nalewany as Chief Financial Officer and confirmed the proposed Board of Directors for the resulting public issuer following its arrangement with Queue Ventures. The Company also confirmed that Custom Health shareholders voted overwhelmingly in favour of the arrangement, with more than 80% of votes cast supporting the transaction.

‍

Completion remains subject to final court, regulatory and third-party approvals, including approval from the Toronto Stock Exchange, and is expected to close in May 2026.

‍‍

‍‍This update includes forward-looking statements regarding the proposed transaction and listing. Actual results may differ materially.